HC
Hansen Carl L. G. disclosed a 19.7% stake in ABCL
Hansen Carl L. G. reported owning 19.7% of AbCellera Biologics Inc. (ABCL) (65,913,149 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G